Aarey Drugs & Pharmaceuticals Limited (BOM:524412)

India flag India · Delayed Price · Currency is INR
94.44
+2.02 (2.19%)
At close: Apr 28, 2026
68.04%
Market Cap 2.69B
Revenue (ttm) 3.91B
Net Income (ttm) 34.35M
Shares Out 28.45M
EPS (ttm) 1.19
PE Ratio 79.12
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 7,648
Average Volume 14,603
Open 92.42
Previous Close 92.42
Day's Range 90.11 - 95.86
52-Week Range 49.01 - 100.00
Beta 0.80
RSI 73.05
Earnings Date May 26, 2026

About BOM:524412

Aarey Drugs & Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients, intermediates, and specialty chemicals for various industrial applications in India. The company offers intermediates, including mono methyl urea, di methyl urea, ortho para nitro anisole, 2-bromomethyl-1,3-dioxolane, and uracil. It also provides active pharmaceutical ingredients, such as metformin HCl, mefenamic acid, and doxofylline. In addition, the company trades chemicals and solvents, including aromatic chemicals, chemical acids, chlor-alkali, ... [Read more]

Industry Medicinal Chemicals and Botanical Products
Founded 1990
Employees 132
Stock Exchange Bombay Stock Exchange
Ticker Symbol 524412
Full Company Profile

Financial Performance

In fiscal year 2025, BOM:524412's revenue was 4.74 billion, an increase of 17.73% compared to the previous year's 4.03 billion. Earnings were 40.24 million, a decrease of -14.09%.

Financial Statements

News

There is no news available yet.